DATA BREACH - 23andMe Jewish & Chinese Consumers May be Affected
Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
23andMe announces CEO’s intention to pursue a potential take-private